Bernard J Zovighian sold $1.7M of EW
CEO at Edwards Lifesciences Corp. 22,430 shares at an average of $76.67, traded Feb 12, 2026, filed Feb 13, 2026.
Score components
- +25RoleCEO
- +25Trade size$1.7M at market
- +5Share of holdings soldSold 21% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001225208-26-001893, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 12, 2026 | MOption exercise Common Stock | +25,350 | $59.26 | $1.5M | 106,326 | Feb 13, 2026 |
| Feb 12, 2026 | SOpen-market sale Common Stock | -2,532 | $77.13 | $195k | 103,794 | Feb 13, 2026 |
| Feb 12, 2026 | SOpen-market sale Common Stock | -19,898 | $76.61 | $1.5M | 83,896 | Feb 13, 2026 |
| Feb 13, 2026 | GGift Common Stock | -2,920 | $0.00 | $0 | 80,976 | Feb 13, 2026 |
| Feb 13, 2026 | GGift Common Stockindirect: By Trust | +2,920 | $0.00 | $0 | 11,517 | Feb 13, 2026 |
| Feb 12, 2026 | MOption exercise Employee Stock Option (Right to Acquire)derivative | -25,350 | $0.00 | $0 | 0 | Feb 13, 2026 |
Related signals
Other insiders at Edwards Lifesciences Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | $53k 619 shares | -2% | |
| 0Weak | Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | $54k 619 shares | -2% | |
| 53Moderate | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $2.0M 23,145 shares | -19% | |
| 34Weak | Edwards Lifesciences Corp | Daveen Chopra CVP, TMTT & Surgical | $127k 1,500 shares | -3% | |
| 68Notable | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $1.5M 17,968 shares | -55% | |
| 25Weak | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $1.8M 22,680 shares | -52% | |
| 4Weak | Edwards Lifesciences Corp | Daniel J. Lippis CVP, TAVR | $87k 1,019 shares | -3% | |
| 32Weak | Edwards Lifesciences Corp | Scott B. Ullem CVP, Chief Financial Officer | $1.1M 13,000 shares | -25% | |
| 30Weak | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $974k 11,340 shares | -35% | |
| 75Notable | Edwards Lifesciences Corp | Donald E Bobo Jr CVP,Strategy/Corp Development | $2.0M 24,000 shares | -53% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.